Supraomohyoid Neck Dissection
No Results
No Results
processing….
Metastatic neck disease is the most important factor in the spread of head and neck squamous cell carcinoma (SCC) from primary sites. The most commonly involved primary sites are the mucosal areas of the upper aerodigestive tract, particularly the larynx, oropharynx, hypopharynx, and oral cavity. Lymph node (LN) metastasis reduces the survival rate of patients with SCC by half. The survival rate is less than 5% in patients who previously underwent surgery and have a recurrent metastasis in the neck. Therefore, control of the neck is one of the most important aspects in the successful management of these particular tumors.
Radical neck dissection is an operation that was created in 1906 to solve the problem of metastatic neck disease. This procedure is a well-designed operation that is relatively easy for the trained head and neck surgeon to learn and to perform. Classic radical neck dissection is still the criterion standard for surgical control of a neck metastasis.
In the last 3 decades, progressive advances have occurred in the understanding of cervical fascial planes, lymphatic drainage patterns, preoperative staging, and extracapsular spread. The necessity to maximize control and to minimize morbidity prompted modifications to the classic neck dissection. One such modification is the preservation of 1 or more nonlymphatic structures (eg, spinal accessory nerve, internal jugular vein [IJV], sternocleidomastoid [SCM] muscle).
Further observations indicated that the pattern of nodal disease depends on the primary site. Therefore, these findings led to another neck dissection modification, which is the selective preservation of 1 or several LN groups. The selected node groups represent the areas of high risk for early metastasis, depending on primary tumor location.
See the list below:
Supraomohyoid or anterolateral – Levels I-III
Lateral – Levels II-IV
Posterolateral – Levels II-V, postauricular and suboccipital
Anterior compartment – Level VI
In 1906, Crile was the first person to describe radical neck dissection, which encompasses the surgical removal of neck metastases contained between superficial and deep fascial layers of the neck. In the 1950s, Martin routinely used radical neck dissection for the management of neck metastasis. The main goal of this procedure was to remove, en bloc, all ipsilateral lymphatic structures from the mandible superiorly to the clavicle inferiorly and from the strap muscles to the anterior border of the trapezius.
The resection included the spinal accessory nerve, the IJV, the SCM muscle, and the submandibular gland. The carotid arteries, vagus nerve, hypoglossal nerves, brachial plexus, and phrenic nerve remained. This operation and its oncologic concept remain valid; however, the procedure has been modified to decrease morbidity while maintaining oncologic efficacy. In the 1960s, Suarez and Bocca independently described a more conservative operation that involved removing all the LNs while sparing the spinal accessory nerve, the SCM muscle, and the IJV. [1, 2]
Studies of the lymphatic system determined the likelihood of particular groups of LNs being involved based on the primary site. This ability to predict the location of metastatic disease was found valid and reliable in further studies. Based on that predictability, in the 1970s, surgeons from the MD Anderson Cancer Center designed a neck operation that spared some LN groups and sacrificed others. The main purpose of this neck operation was to create a more conservative and cosmetically oriented surgery without the decrease of oncologic control.
Multiple modifications to the radical neck operation necessitated the coining of neologisms to describe such changes; the terms for the same modification varied from author to author. These new varied and unclear terms created confusion among clinicians from different geographical areas and institutions. Therefore, standardization was necessary. In 1991, the American Academy of Otolaryngology-Head and Neck Surgery (AAOHNS) published an official report that standardized the terminology for different types of neck dissection. [3]
The report was updated and published in 2002 with only a few changes. These dealt with the application of various types of selective neck dissection procedures for oral cavity cancer, pharyngeal and laryngeal cancer, thyroid cancer, and cutaneous malignancies. [4] In addition, 2 new neck sublevels, Va and Vb, were added, for a total of 6 neck levels and 6 neck sublevels. (The 1991 version of the report listed only 4 neck sublevels.) With the exception of the 2 added neck sublevels, the terminology in the updated report is the same as that of the 1991 version. [5]
The Committee for Neck Dissection of the American Head and Neck Society presented a Classification in 2008 based on 4 types of neck dissection, as follows: [6]
Radical neck dissection: It is considered “the standard neck dissection,” including the resection of the lymphatic nodes in levels I, II, III, IV and V, as well as the sternocleidomastoid muscle, the spinal accessory nerve, and the internal jugular vein.
Modified radical neck dissection: It is considered oncologically as radical as the radical neck dissection, removing the same lymphatic node levels but with preservation of at least 1 of the nonlymphatic structures. [7]
Extended radical neck dissection: It is considered extended in the sense that additional lymphatic nodes as well nonlymphatic structures are removed.
Selective neck dissection: It is a neck dissection in which one or more selected lymph node levels are preserved.
In 2010 the American Academy of Otolaryngology Head and Neck Surgery suggested a new terminology, more precise and easier to understand, in order to further standardize and make it easier to compare neck dissections and neck dissection results around the globe. An international effort was made to identify a rational classification format for neck dissections. The consensus was published in 2011.
This new classification system is based on 3 key terms from the new nomenclature. The first term is ND for “neck dissection.” The second term is a Roman numeral indicating the lymphatic node level and sublevel removed during the dissection. The third term indicates the nonlymphatic structure included in the dissection. [8, 9]
Lymphatic metastasis is the most important mechanism in the spread of head and neck SCC. The risk of LN involvement by metastasis varies depending on the site of origin, size, histologic grade of the primary tumor, perineural invasion, perivascular invasion, and extracapsular spread. Management of the neck LNs is an integral part of treatment of head and neck cancer. Conversely, no single standardized treatment for cervical metastasis is available.
The indications for and type of neck dissection to be performed in the N+ neck and management of the N0 neck remain controversial. Management is based on personal experience and many retrospective studies.
Radical neck dissection was the first attempt to treat metastatic cervical lymphadenectomy adequately. The classic operation was modified several times to decrease morbidity without decreasing oncologic control. The 2 modifications commonly used today are the modified radical and the selective neck dissections.
Incidence of metastatic disease for the upper aerodigestive tract varies from 1-85%, depending on the site, size, and differentiation of the tumor.
In the 1970s, several clinical studies revealed that nodal metastasis to the neck occurs in the following predictable patterns:
Carcinomas of the oral cavity involve mostly the jugulodigastric and midjugular nodes.
Lesions in the floor of the mouth or near the midline frequently cause metastasis bilaterally.
Sites localized in the oral cavity, oral mucosa, oropharynx, hypopharynx, and supraglottis have a higher incidence of metastasis than areas such as the superior gingiva, hard palate, and glottis.
Anterior portions of the oral cavity are associated with smaller risk of neck metastasis than the posterior portions.
Young patients with oral carcinoma have a higher risk of nodal metastasis than older patients.
The larger the primary tumor and/or the greater the depth of penetration, the higher the risk of neck involvement by metastasis.
Perineural and perivascular invasion are associated with a high risk of nodal metastasis.
Extracapsular spread carries a high probability for lymphatic spread.
Poorly differentiated tumors are associated with a higher risk of neck metastasis.
Several retrospective reviews of specimens from radical neck dissections in the 1990s proved that SCCs of the oral cavity most commonly involve nodal levels I-III; level IV is involved 20% of the time, and level V is involved 4% of the time. Furthermore, SCCs at the hypopharyngeal level commonly metastasize to levels II-IV; metastasis to level I occurs 10% of the time, and metastasis to level V occurs 11% of the time. SCCs of the larynx are associated with similar areas and percentages, mostly to levels II-IV (level I, 8%; level V, 5%). Therefore, based on these patterns of nodal metastasis in SCCs, supraomohyoid neck dissection is an adequate node sampling procedure for cancer of the oral cavity.
Supraomohyoid neck dissection carries a recurrence rate of 5% in the N0 neck, 10% in the N+ neck with a single positive node, and 25% when multiple positive nodes or extracapsular spread is present. Supraomohyoid neck dissection is performed for the surgical control of early metastatic neck disease in a selected group of patients with SCCs of the oral cavity and skin cancer of the lip and face.
Metastasis occurs frequently in malignancies. The tumor grows at the primary site by malfunctions in cellular proliferation, differentiation, and death. Mutations due to chemical carcinogens, radiation, or viruses may cause normal cells to allow the activation of oncogenes; multiple genetic mutations, activation of proto-oncogenes, inactivation of tumor suppressor genes, or a combination cause alterations in growth control. Tumor cells move through the basement lamina of the epithelium and the stroma into the lymphatic and vascular channels (ie, cells move from carcinoma in situ to microinvasive tumor). This process is associated with the production of cytokines, enzymes, and growth factors that destroy the basement membrane, thus creating abnormal angiogenesis, which, in turn, triggers neovascularization and growth. The tumor spreads into the regional LNs from the lymphatic and vascular channels and sets up tumors in secondary sites.
Most candidates for supraomohyoid neck dissection present with early stage, (N0 or N1) metastatic neck disease due to SCC of the oral cavity. Usually, the patient is already aware of the primary lesion or it is found easily during physical examination of the upper aerodigestive tract. In 15% of patients, the neck mass is present without an obvious primary lesion.
The most important prognostic factor in patients with SCC of the head and neck is the status of the neck nodes. The status of the cervical nodes constitutes the N portion of the tumor, node, metastases (TNM) classification by the American Joint Committee on Cancer (AJCC). The AJCC assigns N1-N3 ratings to different degrees of neck adenopathy, with subgroupings of a, b, and c for certain stages. The nodal classification is as follows:
NX – Cervical neck nodes not assessable
N0 – No cervical node metastasis
N1 – Single ipsilateral node metastasis (≤3 cm diameter)
N2a – Single ipsilateral node (>3 cm but ≤6 cm diameter)
N2b – Multiple positive ipsilateral nodes (none >6 cm diameter)
N2c – Bilateral or contralateral positive nodes (none >6 cm diameter)
N3 – Massive adenopathy (>6 cm diameter)
Accuracy of staging relates to the physician’s ability to detect cervical adenopathy. Palpation is the technique used most to detect neck metastases. Although palpation is inexpensive and easy to perform, it is not totally reliable.
Sensitivity and specificity of neck examination by palpation range from 60-70%. A short obese neck and/or previous radiation or surgery makes the physical examination more difficult to perform. Negative palpation findings of the neck still indicate a risk of occult metastatic disease. This risk increases according to the site, size, and particular characteristics of the primary lesion.
Imaging is an important part of clinical diagnosis and staging. However, imaging is indicated only if results are used in treatment management. Among these techniques are computed tomography (CT) scanning, magnetic resonance imaging (MRI), ultrasonography, and ultrasound-guided aspiration cytology.
CT scan reveals metastatic adenopathy by central necrosis and extracapsular spread by enhancement of the nodal capsule. MRI is less precise than CT scan in identifying tumor necrosis and extracapsular spread, but MRI is better in assessing enlarged LNs that do not necessarily represent metastasis. Both techniques are incapable of detecting lymph nodes smaller than 1 cm. which, on occasion, independently of the size, are involved in metastasis. Ultrasound-guided aspiration cytology has a higher specificity than either CT or MRI in analyzing lymph nodes, particularly in smaller nodes of less than 10 mm. However, the yield of this technique is directly related to the experience of the ultrasonographer and the pathologist.
Positron emission tomography (PET) has been used recently to assist in the diagnosis of LN metastasis. PET provides information about the metabolic activity of the tissues. Tissues with squamous cell carcinoma cells capture18 fluoro-2-deoxy-D-glucose (FDG) at increased rates compared to normal tissues. Therefore, a minimal amount of tumor tissue must be present to be positive and its precision is limited in tumors smaller than 1 cm. The precision of PET is limited to around 5 mm.
Recent literature has demonstrated the higher sensitivity and specificity of the (FDG)–PET compared with ultrasonography, CT scan and MRI in the assessment of metastatic staging of neck carcinomas. This finding could signify a positive role for PET in the identification of metastatic disease in patients with a clinically N0 neck. PET findings could provide early diagnosis of recurrent head and neck cancer, as well as indicate the status of the neck after chemo-radiotherapy.
New challenges have been recognized in the last 15 years with the selection of candidates for neck dissection who were treated initially with organ preservation treatment protocols and who may have persistence of neck disease after the nonoperative management. This group of patients can benefit greatly from the routine use of posttreatment PET/CT during their assessment for subsequent surgical management of the neck.
PET and PET/CT are discussed further in Workup.
Intraoperative findings are important in the supraomohyoid neck dissection. An intraoperative evaluation by the surgeon or pathologist can alter the course of surgery. The criterion standard for detection of LN metastasis in the neck is careful histologic examination and evaluation of all nodes by the pathologist after the neck dissection is completed.
Detection and accurate staging of neck metastasis are extremely important because staging has major implications for prognosis and treatment. Head and neck surgeons at the Memorial Sloan-Kettering Hospital originally developed the most widely accepted terminology used to define regions of involvement of cervical LN groups. The terminology is as follows:
Region/level I – Submental and submandibular nodes
Ia – Nodes in the submental triangle bound by the anterior belly of the digastric muscle and the hyoid bone
Ib – Nodes in the triangle bound by the anterior and posterior bellies of the digastric muscle and body of the mandible
Region/level II – Upper jugular LNs (including the jugulodigastric nodes)
IIa – Nodes in the region anterior to the spinal accessory nerve
IIb – Nodes in the region posterior to the spinal accessory nerve
Region/level III – Nodes from the carotid bifurcation to the omohyoid muscle
Region/level IV – Nodes of the lower jugular area that extend from the omohyoid to the clavicle
Region/level V – All LNs within the posterior triangle of the neck
Region/level VI – Nodes in the anterior compartment group, which includes the LNs that surround the midline structures of the neck (These nodes extend from the hyoid bone superiorly to the suprasternal notch inferiorly.)
The revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology Head and Neck Surgery Committee and published in 2002 recommended the use of 6 neck levels and 6 sublevels, which added 2 extra sublevels (a and b) at level V. The 6 sublevels are Ia (submental nodes), Ib (submandibular nodes), IIa and IIb (upper jugular nodes), Va (spinal accessory nodes), and Vb (transverse cervical and supraclavicular nodes). [4, 5]
No single set of indications exists for supraomohyoid neck dissection. They vary among authors and institutions around the world. Management strategies discussed in this article are based on recent publications. However, no medical dogma exists and the need for a particular surgery should be based on a case-by-case evaluation that considers the condition of the patient, the surgeon’s expertise and the institution’s capabilities.
The current general opinion is that selective neck dissection is a good alternative for the N0 neck in persons with squamous cell carcinoma (SCC) of the oral cavity. [10] Therefore, supraomohyoid neck dissection is commonly used for this purpose, if the primary lesion is not treated with radiation therapy. [9]
An extended supraomohyoid neck dissection that involves the removal of lymph nodes from levels I through IV has been advocated by certain surgeons if the primary lesion involves the oral tongue subunit. These surgeons have found that approximately 16% of patients with oral tongue lesions develop level IV metastasis, skipping the lower levels. Conversely, other surgeons have found only 2% of patients with metastasis at level IV in T1-T3 N0 oral tongue cancer and they believe in excising level IV only when intraoperative suspicion of metastasis is found at level II or III. Other surgeons believe that if the intraoperative pathology evaluation reveals metastasis at any level an extended supraomohyoid dissection must be performed. However, apart from these differences, most authors agree that supraomohyoid neck dissection for SCC of the oral cavity with an N0 neck is as effective as radical neck dissection. [11]
Indications are less clear in the clinically N+ neck for SCC of the oral cavity. Standardization is lacking. [12] Some authors do not advocate a supraomohyoid neck dissection for the N+ neck. Other authors believe that a supraomohyoid neck dissection is effective for the N1 neck and even the N2a neck in carefully selected patients. Most authors generally agree, however, that the presence of metastatic neck nodes cuts the survival rates by half. In the authors’ institution, in the case of an N+ neck with an oral cavity primary tumor, whenever possible we use the comprehensive neck dissection, which involves dissection of levels I through V.
A consensus believes that a bilateral supraomohyoid neck dissection is indicated when the location of the primary tumor SCC of the oral cavity has a high risk of developing metastasis in both sides of the neck, (eg, floor of the mouth, ventral or midline dorsal tongue) and postoperative radiation therapy is not planned.
The literature provides no clear consensus regarding nonmelanocytic facial carcinomas. Therefore, treatment depends mostly on the size of the primary tumor. Some authors perform a supraomohyoid neck dissection in the early stages of SCC of the lip and skin of the cheek. A bilateral neck dissection is done if the tumor is close to the midline.
An understanding of the relevant neck anatomy is required to perform a supraomohyoid neck dissection adequately. From the surgical point of view, each side of the neck is divided into 2 cervical triangles (ie, anterior, posterior).
The inferior border of the mandible, the SCM muscle, and the strap muscle form the anterior cervical triangle. This triangle is subdivided into 4 smaller triangles (ie, submandibular, submental, muscular, carotid). Understanding and identifying each of these areas guides the surgeon in completely removing the contents of the anterior cervical triangle.
Submandibular triangle: The inferior border of the mandible and the 2 bellies of the digastric muscle delineate the submandibular triangle. The mylohyoid and hyoglossus muscles form the floor. The submandibular area contains the submandibular gland, lymphatic structures, anterior facial vein, and facial artery. The lingual nerve is above the muscular floor and below the deep layer of the deep cervical fascia.
Submental triangle: The anterior belly of the digastric muscle, the hyoid bone, and the midline of the neck delineate the submental triangle. The mylohyoid muscle forms the floor of the submental triangle, which contains a few LNs and small tributaries of the anterior jugular vein.
Muscular triangle/carotid triangle: The omohyoid muscle in the anterior cervical triangle delineates the muscular triangle below and the carotid triangle above.
The posterior cervical triangle also is referred to as the lateral cervical triangle. This triangle is limited by the anterior margin of the trapezius muscle, the posterior border of the SCM muscle, and the middle third of the clavicle. The posterior aspect of the omohyoid muscle further subdivides the posterior cervical triangle into 2 smaller triangles: the occipital triangle located above the omohyoid muscle and the supraclavicular triangle located inferiorly to the muscle.
Cervical LNs are divided into superficial and deep chains. Superficial LNs are involved in a late stage of cancer; therefore, superficial LNs have less oncologic importance. Deep cervical LNs receive drainage from areas of the mouth, pharynx, larynx, salivary glands, thyroid, and the skin of the head and neck. These deep cervical LNs (ie, superior, middle, inferior) accompany the IJV and its branches.
Oncologically, the superior jugular nodes (the group that lies near the anterosuperior aspect of the accessory nerve) are crucial. These nodes represent the most difficult area in the resection of the deep jugular nodes.
The cervical LNs localized in the posterior triangle of the neck are classified into upper, middle, and inferior cervical nodes. Posterior triangle nodes are located beneath the upper portion of the SCM muscle and run posteriorly along the course of the spinal accessory nerve. This group of lymphatics receives drainage from the nasopharynx and communicates directly with the upper deep nodes from the IJV.
The posterior triangle nodes in the inferior aspect progress anteriorly to the supraclavicular area to join the IJV at the base of the neck. The above groups are easier to understand when divided into levels or zones, as follows:
level I – Nodal group that involves submental and submandibular regions (also referred to as IA and IB)
level II – Upper jugular group (IIa nodes in the region anterior to the spinal accessory nerve, IIb nodes in the region posterior to the spinal accessory nerve)
level III – Middle jugular group
level IV – Lower jugular group
level V – Posterior triangle group (Va spinal accessory nodes, Vb transverse cervical and supraclavicular nodes)
level VI – Central anterior neck group
The rectangular and sheetlike platysma muscle extends obliquely from the upper chest to the lower face, from posteroinferior to anterosuperior. Its undersurface creates an ideal plane in which to elevate the skin flaps in neck dissection. The platysma muscle is deficient in the lower anterior midline in the neck and posterior to the external jugular vein (EJV) and greater auricular nerve.
The SCM muscle runs from anteroinferior to posterosuperior and attaches to the mastoid tip. The greater auricular nerve and the EJV cross the upper aspect of the muscle. These structures guide the surgeon to the right plane of dissection and should be left on the surface of the SCM during flap elevation. The fascial envelope of the muscle is a key structure for selective neck dissections.
The spinal accessory nerve crosses over the IJV in approximately 70% of individuals. The nerve is also medial to the posterior belly of the digastric and stylohyoid muscles. Anatomic variations include the nerve that runs medially to the IJV in 30% of individuals and through the vein in 3% of individuals. Attention to this fact avoids damage to the IJV during the dissection of cranial nerve XI in the upper aspect of the neck. The nerve enters obliquely to the SCM muscle, from superior to inferior, with the exit at the Erb point, which is near the greater auricle nerve at the posteroinferior edge of the SCM muscle.
The posterior belly of the digastric muscle is an important landmark. This belly extends from the hyoid bone to the undersurface of the mastoid tip. Important and delicate structures are recognized medial to the muscle. Therefore, the posterior belly of the digastric muscle lies superficial to the external and internal carotid arteries, hypoglossal nerve, and IJV. Lateral to the posterior belly of the digastric muscle, the only structure that requires preservation is the marginal mandibular nerve.
The marginal mandibular nerve is localized deep to the superficial layer of the deep cervical fascia that covers the submandibular gland and lies superficial to the anterior facial vein. The best way to preserve the nerve is to identify it carefully at the above locations. Once the nerve is identified, tissue lateral and inferior to the nerve can be divided to expose the posterior belly of the digastric muscle.
The trapezius muscle extends from the posterior occiput to the lateral third of the clavicle. The anterior border of the trapezius is the posterior edge of level V, or the posterior triangle, of the neck.
Like the digastric muscle, the omohyoid muscle has 2 bellies. The anterior belly is superficial to the IJV. The posterior belly is superficial to the brachial plexus, phrenic nerve, and transverse cervical artery and vein. Like the digastric muscle, the omohyoid is a key anatomic landmark in radical neck dissection.
The vagus nerve in the neck is intimately associated with the carotid sheath and lies immediately deep to the IJV. Intraoperatively, the vagus nerve can be injured during dissection and division of the lower portion of the IJV. Identification of the vagus nerve before division of the IJV is mandatory.
The hypoglossal nerve in the neck travels under the IJV, passes over the internal and external carotid arteries, and continues inferomedially to the posterior belly of the digastric muscle to enter the tongue musculature. Identification is important to avoid injury.
The phrenic nerve lies above the anterior scalene muscle and deep to the transverse cervical artery. The brachial plexus exits lower in the neck and then passes between the anterior and middle scalene muscles. Identify anterior and middle scalene muscles before clamping lymphatic structures. Avoid dissection in the supraclavicular area before phrenic and brachial plexus visualization.
The thoracic duct, located in the lower left neck, arises posterior to the IJV and anterior to the phrenic and transverse cervical artery. The anatomy varies, and the duct has multiple interdigitated channels.
See Neck Anatomy, Vagus Nerve Anatomy, Brachial Plexus Anatomy, and Thoracic Duct Anatomy for more information.
The contraindications to supraomohyoid neck dissection are obvious once the indications are understood.
In summary:
The indications to supraomohyoid neck dissection are SCC of the oral cavity, T1-T4, and N0. Supraomohyoid neck dissection is both diagnostic and therapeutic in patients with N0. On this point, authors generally agree.
However, the treatment role of supraomohyoid neck dissection in patients with positive neck disease (N+) is more controversial. Some authors consider the supraomohyoid neck dissection an adequate treatment for selected N1 and N2a necks. Other authors, however, favor extending the dissection to levels IV and V.
Therefore, the contraindication to supraomohyoid neck dissection is any SCC of the oral cavity in which the clinical neck stage is other than. N0, N1, or N2a.
Suarez O. El problema de las metastasis linfaticas y alejadas del cancer de laringe e hipofaringe. Rev. Otorrinolaringol. 1963. 23:83-99.
Bocca E, Pignataro O. A conservation technique in radical neck dissection. Ann Otol Rhinol Laryngol. 1967 Dec. 76(5):975-87. [Medline].
Robbins KT. Pocket Guide to Neck Dissection Classification and TNM Staging of Head and Neck Cancer. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. 1991:7-9.
Robbins KT. Pocket Guide to Neck Dissection and Classification and TNM Staging of Head and Neck Cancer, American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. 2001. 8-38.
Robbins K. T., Clayman G., Levine P. A., Medina J. , Sessions R., Shaha A., et al. Neck Dissection Classification Update: Revisions Proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. July 2002. 128 (7):751-758.
Robbins KT, Shaha AR, Medina JE, et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008 May. 134(5):536-8. [Medline].
Guo CB, Feng Z, Zhang JG, Peng X, Cai ZG, Mao C, et al. Supraomohyoid neck dissection and modified radical neck dissection for clinically node-negative oral squamous cell carcinoma: A prospective study of prognosis, complications and quality of life. J Craniomaxillofac Surg. 2014 Aug 6. [Medline].
Ferlito A, Robbins KT, Shah JP, Medina JE, Silver CE, Al-Tamimi S. Proposal for a rational classification of neck dissections. Head Neck. 2011 Mar. 33(3):445-50. [Medline].
Medina JE, Vasan NR. Neck Dissection. Johnson, Rosen. Bailey’s Head and Neck Surgery Otolaryngology. Fifth Edition. Walters Klumer, Lippincott William & Wilkins; 2014. Vol. II: 1807-1838/117.
Kowalski L P, Sanabria A. Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol. Ital. June 2007. 27 (3):113-117.
Feng Z, Li JN, Niu LX, Guo CB. Supraomohyoid neck dissection in the management of oral squamous cell carcinoma: special consideration for skip metastases at level IV or V. J Oral Maxillofac Surg. 2014 Jun. 72(6):1203-11. [Medline].
Ferlito A, Silver CE, Rinaldo A. Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg. Jan 2009. 47(1):5-9. [Medline].
Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006 Mar. 112(3 Pt 2 Suppl 109):1-15. [Medline].
Pitman KT, Ferlito A, Devaney KO, Shaha AR, Rinaldo A. Sentinel lymph node biopsy in head and neck cancer. Oral Oncol. 2003 Jun. 39(4):343-9. [Medline].
Sebbesen L, Bilde A, Therkildsen M, Mortensen J, Specht L, von Buchwald C. 3 years follow-up of sentinel node negative patients with early oral cavity squamous cell carcinoma. Head Neck. Jun 26 2013.
Seethala RR. Current state of neck dissection in the United States. Head Neck Pathol. Sep 2009. 3(3):238-245. [Full Text].
Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res. 2008 Feb 15. 14(4):1002-14. [Medline].
Shores CG, Yin X, Funkhouser W, Yarbrough W. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004 Aug. 130(8):937-42. [Medline].
Kos M, Engelke W. Advantages of a new technique of neck dissection using an ultrasonic scalpel. J Craniomaxillofac Surg. Jan 2007. 35(1):10-14. [Medline].
Salami A, Dellepiane M, Bavazzano M, Crippa B, Mora F, Mora R. New trends in head and neck surgery: a prospective evaluation of the Harmonic Scalpel. Med Sci Monit. 2008/05. 14 (5):PI1-5. [Medline].
Byeon HK, Holsinger FC, Koh YW, et al. Endoscopic supraomohyoid neck dissection via a retroauricular or modified facelift approach: preliminary results. Head Neck. 2014 Mar. 36(3):425-30. [Medline].
Byeon HK, Holsinger FC, Koh YW, Ban MJ, Ha JG, Park JJ, et al. Endoscopic supraomohyoid neck dissection via a retroauricular or modified facelift approach: preliminary results. Head Neck. 2014 Mar. 36(3):425-30. [Medline].
Lee HS, Kim WS, Hong HJ, Ban MJ, Lee D, Koh YW, et al. Robot-assisted Supraomohyoid neck dissection via a modified face-lift or retroauricular approach in early-stage cN0 squamous cell carcinoma of the oral cavity: a comparative study with conventional technique. Ann Surg Oncol. 2012 Nov. 19(12):3871-8. [Medline].
Adams S, Baum RP, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998 Sep. 25(9):1255-60. [Medline].
Andersen PE, Warren F, Spiro J, Burningham A, Wong R, Wax MK. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg. 2002 Oct. 128(10):1180-4. [Medline].
Argiris A, Eng C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res. 2003. 114:15-60. [Medline].
Aygun Nafi, Oliverio PJ, Zinreich S J. Overview of Diagnostic Imaging of the Head and Neck, chapter 2 in Cummings Otolaryngology Head and Neck Surgery. Fourth Edition. Elsevier Mosby; 2005. Volume One: 25-92.
Bier-Laning CM. Surgical Complications of the Neck, chapter 117 in Cummings Otolaryngology Head and Neck Surgery, Fourth Edition, Volume Three. 2005. Elsevier Mosby:2646-2657.
Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997 Jan. 19(1):14-9. [Medline].
Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990 May-Jun. 12(3):197-203. [Medline].
Charron M, Beyer T, Bohnen NN, Kinahan PE, Dachille M, Jerin J. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med. 2000 Nov. 25(11):905-10. [Medline].
Crean SJ, Hoffman A, Potts J, Fardy MJ. Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head Neck. 2003 Sep. 25(9):758-62. [Medline].
Dogan E, Cetinayak HO, Sarioglu S, Erdag TK, Ikiz AO. Patterns of cervical lymph node metastases in oral tongue squamous cell carcinoma: implications for elective and therapeutic neck dissection. J Laryngol Otol. 2014 Mar. 128(3):268-73. [Medline].
Farber LA, Benard F, Machtay M, Smith RJ, Weber RS, Weinstein GS. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope. 1999 Jun. 109(6):970-5. [Medline].
Ferlito A, Rinaldo A, Robbins KT, Silver CE. Neck dissection: past, present and future?. J Laryngol Otol. 2006 Feb. 120(2):87-92. [Medline].
Gavilan C, Gavilan J, Monux. Vaciamiento glanglionar cervical funcional, capitulo XXIV. Gil Carcedo LM, ed. El Abordaje en el Tratamiento Quirúrgico de los Tumores de Cabeza y Cuello. 1992. 361-372.
Gavilan J, Gavilan C, Herranz J. Functional neck dissection: three decades of controversy. Ann Otol Rhinol Laryngol. 1992 Apr. 101(4):339-41. [Medline].
Gavilan J, Herranz J, DeSanto L W, Gavilan C. Functional and Selective Neck Dissection, Thieme Medical Publishers, Inc. 2002. 1-143.
Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope. 1999 Jun. 109(6):880-5. [Medline].
Johnson J. Cervical metastases. Gludkman, Gullane, Johnson, eds. Practical Approach to Head and Neck Tumors. Raven Book; 1994. chap 4.
Khafif A, Lopez-Garza JR, Medina JE. Is dissection of level IV necessary in patients with T1-T3 N0 tongue cancer?. Laryngoscope. 2001 Jun. 111(6):1088-90. [Medline].
Kowalski LP, Carvalho AL. Feasibility of supraomohyoid neck dissection in N1 and N2a oral cancer patients. Head Neck. 2002 Oct. 24(10):921-4. [Medline].
Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope. 2000 Sep. 110(9):1493-7. [Medline].
Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000 Feb. 18(3):651-8. [Medline].
Lowe VJ, Stack Jr BC, Watson Jr RE. Head and Neck Cancer Imaging, chapter 3 in Head and Neck Cancer, Emerging Perspectives (Ensley J. F, Gutkind J.S., Jacobs J. R., Lippman S. M., editors). 2003. 23-33.
Medina J E. Management of the Neck in Squamous Cell Carcinomas of the Head and Neck, chapter 22 in Head and Neck Cancer, Emerging Perspectives (Ensley J. F, Gutkind J.S., Jacobs J. R., Lippman S. M., editors). 2003. 317-327.
Medina J E, Houck Jr JR, O’Malley B B. Management of Cervical Lymph Nodes in Squamous Cell Carcinoma of the Head and Neck, chapter 16, Head and Neck Cancer, A Multidisciplinary Approach (Harrison L. B., Sessions R. B., Hong W. K., editors). 1999. 353-377:
Medina JE. A rational classification of neck dissections. Otolaryngol Head Neck Surg. 1989 Mar. 100(3):169-76. [Medline].
Medina JE. Neck Dissection, chapter 113, in Head & Neck Surgery-Otolryngology, (Bailey B.J. & Johnson J. T.,editors),. Fourth Edition. Lippincoott Williams & Wilkins; 2006. Volume Two: 1585-1609.
Medina JE. Selective Neck Dissection [videotape]. Continuing Education with Television (CETV). 1987.
Medina JE, Byers RM. Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck. 1989 Mar-Apr. 11(2):111-22. [Medline].
Medina JE, Lore Jr J M. The Neck, chapter 16 in An Atlas of Head and Neck Surgery, (Lore & Medina, editor), Fourth Edition. Elsevier Saunders, 2005. 780-817.
Medina JE, Weisman RA. The Otolaryngology Clinics of North America. Vol 1. August 1998. 585-686.
Myers EN. Chapter 78, Neck Dissection. Operative Otolaryngology Head and Neck Surgery. 2nd Edition. Elsevier; 2008. Vol 1: 679-708.
Myers LL, Wax MK, Nabi H, Simpson GT, Lamonica D. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope. 1998 Feb. 108(2):232-6. [Medline].
Rassekh CH, Johnson JT, Myers EN. Accuracy of intraoperative staging of the NO neck in squamous cell carcinoma. Laryngoscope. 1995 Dec. 105(12 Pt 1):1334-6. [Medline].
Robbins K T. Neck Dissection, chapter 116 in Cummings Otolaryngology Head and Neck Surgery. Fourth Edition. Elsevier Mosby,; 2005. Volume Three: 2614-2645.
Robbins KT. Neck Dissection. Cummings, Fredrickson, Harker, Krause, Richardson, Schuller. Otolaryngology Head Neck Surgery. 3rd ed. Mosby Book; 1998. Vol 3: 1787-1810.
Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990 Oct. 160(4):405-9. [Medline].
Shah JP, Andersen PE. The impact of patterns of nodal metastasis on modifications of neck dissection. Ann Surg Oncol. 1994 Nov. 1(6):521-32. [Medline].
Shockley WW, Pillsbury III HC. The Neck: Diagnosis and Surgery. Mosby Book; 1994. 413-429.
Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999 Jul. 26(7):767-73. [Medline].
Procedure Step
Surgical Steps and Pearls
Supraomohyoid neck dissection/definition
It is also called anterolateral neck dissection.
It consists of removal of cervical lymphatic nodes contained in neck levels I, II and III.
It is generally used as a selective neck dissection in patients with squamous cell carcinoma of the oral cavity, T1-T4 and N0, if the primary lesion is not to be treated with radiation therapy. In this manner, the supraomohyoid neck dissection is both diagnostic and therapeutic.
In the N+ neck, standardization is lacking; see text for a detailed description of indications and contraindications.
Incision design
Try not to use trifurcation incisions.
The recommended incisions for unilateral neck dissection are the modified apron incision or the inverted hockey stick incision.
The recommended incisions for bilateral neck dissection are the apron incision or the bilateral inverted hockey stick incision.
Skin incision and skin and subplatysmal flap elevation
Elevate the skin and subplatysmal flap to the level of the body of the mandible.
Expose the anatomy of the submandibular, submental, and carotid triangles.
Leave the external jugular vein and the greater auricular nerve on the SCM muscle.
Elevation posterior to the SCM muscles is unnecessary.
level I dissection
Identify the mandibular nerve and elevate it, along with the surrounding tissue, in its own plane.
Remove the submental fatty tissue and identify the anterior belly of the digastric muscle.
Follow the anterior belly of the digastric muscle and identify the mylohyoid muscle.
Retract anteriorly the mylohyoid and expose the submandibular ganglion, lingual nerve, and submandibular duct. Divide and ligate the submandibular duct.
Clamp, divide, and ligate the facial artery.
Remove the submandibular gland and the submandibular lymph nodes.
Identify the hypoglossal nerve deep into the fascia of the submandibular triangle.
Identify and expose completely the posterior belly of the digastric muscle up to the mastoid tip.
If the facial artery is reencountered at this point, tie it and ligate it.
After completion of all of the above, dissect and displace inferiorly the submental fatty tissue, submandibular nodes, and submandibular gland.
Fascial peeling of SCM
Ligate the external jugular vein.
Grasp the fascia over the SCM and peel it from the muscle.
The accessory nerve is encountered in the upper portion of the SCM during the peeling maneuver. Identify the accessory nerve directly by sight or indirectly with nerve stimulation.
Dissection posterior and inferior to the SCM
Continue inferiorly the dissection of fibroadipose tissue along the posterior border of the SCM muscle to the level of the omohyoid muscle.
Identify and follow the sensory branches of the cervical plexus and continue the dissection lateral to these nerves.
Follow the sensory branches of the cervical plexus from posterior to anterior in order to reach the carotid sheath.
Identify and protect the cervical plexus and the phrenic and vagus nerves.
Carotid sheath, vagus nerve, internal jugular vein
Identify the carotid sheath, the vagus nerve, and the internal jugular vein.
Unwrap the carotid sheath, freeing it of tissue containing nodes, working in an inferior to superior direction.
Identify the vagus nerve and preserve it.
Do the same with the internal jugular vein.
Identify, clamp, and ligate the branches of the internal jugular vein.
Completion and removal of specimen
Follow the superior belly of the omohyoid muscle to the hyoid bone.
Divide and ligate the ranine veins.
Identify and preserve the superior thyroid artery and the hypoglossal nerve.
Complete the dissection at this point by removing the specimen.
Antonio Riera March, MD, FACS Professor, Department of Otolaryngology-Head and Neck Surgery, University of Puerto Rico School of Medicine
Antonio Riera March, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, Society for Ear, Nose and Throat Advances in Children, American Cleft Palate-Craniofacial Association, American College of Surgeons
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Karen H Calhoun, MD, FACS, FAAOA Professor, Department of Otolaryngology-Head and Neck Surgery, Ohio State University College of Medicine
Karen H Calhoun, MD, FACS, FAAOA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Head and Neck Society, Association for Research in Otolaryngology, Southern Medical Association, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Rhinologic Society, Society of University Otolaryngologists-Head and Neck Surgeons, Texas Medical Association
Disclosure: Nothing to disclose.
Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;Cliexa;Preacute Population Health Management;The Physicians Edge<br/>Received income in an amount equal to or greater than $250 from: The Physicians Edge, Cliexa<br/> Received stock from RxRevu; Received ownership interest from Cerescan for consulting; for: Rxblockchain;Bridge Health.
Benoit J Gosselin, MD, FRCSC Associate Professor of Surgery, Dartmouth Medical School; Director, Comprehensive Head and Neck Oncology Program, Norris Cotton Cancer Center; Staff Otolaryngologist, Division of Otolaryngology-Head and Neck Surgery, Dartmouth-Hitchcock Medical Center
Benoit J Gosselin, MD, FRCSC is a member of the following medical societies: American Head and Neck Society, American Academy of Facial Plastic and Reconstructive Surgery, North American Skull Base Society, American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Rhinologic Society, Canadian Medical Association, Canadian Society of Otolaryngology-Head & Neck Surgery, College of Physicians and Surgeons of Ontario, New Hampshire Medical Society, Ontario Medical Association
Disclosure: Nothing to disclose.
Juan Trinidad Pinedo, MD, FACS Ad-Honorem Professor, Department of Otolaryngology-Head and Neck Surgery, University of Puerto Rico Medical School
Juan Trinidad Pinedo, MD, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, and Puerto Rico Medical Association
Disclosure: Nothing to disclose.
Acknowledgments
The authors and editors of Medscape Drugs & Diseases wish to acknowledge Joan Flaherty, RN, for her editorial assistance and Gustavo Díaz, MD, for taking the digital surgical photos.
Supraomohyoid Neck Dissection
Research & References of Supraomohyoid Neck Dissection|A&C Accounting And Tax Services
Source
0 Comments